Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn

Latest Articles

  • Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
    You have access
    Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
    Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, Uwe Grether, Allyn C. Howlett, Tian Hua, Alexandros Makriyannis, Daniele Piomelli, Natsuo Ueda and Mario van der Stelt
    Charles France, Associate Editor
    Pharmacological Reviews September 2023, 75 (5) 885-958; DOI: https://doi.org/10.1124/pharmrev.122.000600
  • You have access
    Optical approaches for investigating neuromodulation and G Protein-Coupled Receptor signaling
    David J Marcus and Michael R. Bruchas
    Pharmacological Reviews July 10, 2023, PHARMREV-AR-2022-000584; DOI: https://doi.org/10.1124/pharmrev.122.000584
  • You have access
    Targeting Epidermal Growth Factor Receptor for Cancer Treatment: Abolishing both Kinase-Dependent and Kinase-Independent Functions of the Receptor
    Yuesheng Zhang
    Pharmacological Reviews June 20, 2023, PHARMREV-AR-2023-000906; DOI: https://doi.org/10.1124/pharmrev.123.000906
  • You have access
    Effects of medications on heat loss capacity in chronic disease patients: health implications amidst global warming
    Jericho Wee, Xiang Ren Tan, Samuel H. Gunther, Mohammed Ihsan, Melvin Khee Shing Leow, Doreen Su-Yin Tan, Johan G. Eriksson and Jason Kai Wei Lee
    Pharmacological Reviews June 16, 2023, PHARMREV-AR-2022-000782; DOI: https://doi.org/10.1124/pharmrev.122.000782
  • You have access
    Oxycodone: A Current Perspective on its Pharmacology, Abuse and Pharmacotherapeutic Developments
    James E. Barrett, Aryan Shekarabi and Saadet Inan
    Pharmacological Reviews June 15, 2023, PHARMREV-AR-2021-000506; DOI: https://doi.org/10.1124/pharmrev.121.000506
  • You have access
    Review of Natural Language Processing in Pharmacology
    Dimitar Trajanov, Vangel Trajkovski, Makedonka Dimitrieva, Jovana Dobreva, Milos Jovanovik, Matej Klemen, Aleš Žagar and Marko Robnik-Šikonja
    Habibeh Khoshbouei, Associate Editor
    Pharmacological Reviews July 2023, 75 (4) 714-738; DOI: https://doi.org/10.1124/pharmrev.122.000715
  • Open Access
    Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment
    Xiaoyi Chen, Yunjiang Feng, Ronald J. Quinn, Dean L. Pountney, Des R. Richardson, George D. Mellick and Linlin Ma
    Habibeh Khoshbouei, Associate Editor
    Pharmacological Reviews July 2023, 75 (4) 758-788; DOI: https://doi.org/10.1124/pharmrev.122.000743
  • Advances in Nanozymes as a Paradigm for Viral Diagnostics and Therapy
    You have access
    Advances in Nanozymes as a Paradigm for Viral Diagnostics and Therapy
    Garima Sharma, Srijan Chatterjee, Chiranjib Chakraborty and Jin-Chul Kim
    Martin Michel, Associate Editor
    Pharmacological Reviews July 2023, 75 (4) 739-757; DOI: https://doi.org/10.1124/pharmrev.122.000719
  • You have access
    Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders
    Martin C. Michel, Linda Cardozo, Christopher J. Chermansky, Francisco Cruz, Yasuhiko Igawa, Kyu-Sung Lee, Arun Sahai, Alan J. Wein and Karl-Erik Andersson
    Lynette Daws, Associate Editor
    Pharmacological Reviews July 2023, 75 (4) 554-674; DOI: https://doi.org/10.1124/pharmrev.121.000523
  • You have access
    Pharmacogenomics: Driving Personalized Medicine
    Wolfgang Sadee, Danxin Wang, Katherine Hartmann and Amanda Ewart Toland
    Hyunyoung Jeong, Associate Editor
    Pharmacological Reviews July 2023, 75 (4) 789-814; DOI: https://doi.org/10.1124/pharmrev.122.000810

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 155
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics